MyFinsight
Home
Blog
About
Contact
Download
Download image
Prepaid expenses and
other current assets
$2,162,696
Marketable securities
$15,956,740
Cash and cash
equivalents
$59,340,599
Right-of-use assets
$340,977
Total current assets
$77,460,035
Total assets
$77,801,012
Total liabilities and
stockholders equity
$77,801,012
Total stockholders
equity
$49,244,543
Total liabilities
$28,556,469
Accumulated deficit
-$477,495,746
Accumulated other
comprehensive (loss) income
$815
Additional paid-in capital
$526,679,311
Operating lease
liabilities, long-term
$72,536
Total current
liabilities
$28,483,933
Common stock, voting,
0.001 par value...
$60,163
Deferred collaboration
revenue, long term
$6,000,000
Operating lease
liabilities
$271,948
Current portion of debt
$15,199,265
Accrued expenses
$6,999,297
Accounts payable
$13,423
Back
Back
Balance Sheet
source: myfinsight.com
Aldeyra Therapeutics, Inc. (ALDX)
Aldeyra Therapeutics, Inc. (ALDX)